THIS EVENING: Investors eyeing share purchases in two state-owned pharma players
Good afternoon, friends, and welcome to a new week. The news cycle is picking up pace, showing no signs that…
Available in your choice of English or Arabic
Good afternoon, friends, and welcome to a new week. The news cycle is picking up pace, showing no signs that…
Good afternoon, friends, and happy almost-THURSDAY. The weekend is within arm’s reach and we’re just about halfway through Ramadan, and…
Good afternoon, ladies and gents, and happy hump day. We’re looking at a Goldilocks news day so far — not…
Good morning ladies and gents. There may be only seven working days remaining of the year but 2022 shows no…
Good morning, wonderful people. Climate is again the big story of the day, as you might expect with just three…
Good morning, friends, and welcome to another uncharacteristically busy August news day. We have an absolutely packed issue for you…
Good morning and Happy Thursday, ladies and gents. We have a packed, M&A-heavy issue for you to close out the…
Good morning, everyone, and welcome to a very busy news day at home and abroad. THE BIG STORY HERE AT…
Something went wrong. Please refresh the page and/or try again.
Queue